OBI Pharma Ownership

4174 Stock  TWD 63.00  0.40  0.63%   
OBI Pharma owns a total of 228.95 Million outstanding shares. OBI Pharma has substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as OBI Pharma in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of OBI Pharma, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in OBI Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

OBI Stock Ownership Analysis

About 37.0% of the company shares are owned by insiders or employees . The book value of OBI Pharma was presently reported as 22.55. The company recorded a loss per share of 8.05. OBI Pharma had not issued any dividends in recent years. OBI Pharma, Inc., a bio-pharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. The company was founded in 2002 and is based in Taipei, Taiwan. OBI PHARMA operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. For more info on OBI Pharma please contact Michael Chang at 886 2 2655 8799 or go to https://www.obipharma.com.

OBI Pharma Outstanding Bonds

OBI Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. OBI Pharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most OBI bonds can be classified according to their maturity, which is the date when OBI Pharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Pair Trading with OBI Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OBI Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OBI Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with OBI Stock

  0.854743 Oneness BiotechPairCorr
  0.916547 Medigen Vaccine BiologicsPairCorr

Moving against OBI Stock

  0.872891 CTBC Financial HoldingPairCorr
  0.862882B Cathay Financial HoldingPairCorr
  0.842881A Fubon Financial HoldingPairCorr
  0.812883 China DevelopmentPairCorr
  0.752317 Hon Hai PrecisionPairCorr
The ability to find closely correlated positions to OBI Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OBI Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OBI Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OBI Pharma to buy it.
The correlation of OBI Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OBI Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OBI Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OBI Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for OBI Stock Analysis

When running OBI Pharma's price analysis, check to measure OBI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OBI Pharma is operating at the current time. Most of OBI Pharma's value examination focuses on studying past and present price action to predict the probability of OBI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OBI Pharma's price. Additionally, you may evaluate how the addition of OBI Pharma to your portfolios can decrease your overall portfolio volatility.